Fluoroquinolone Use and Risk Factors for Clostridium difficile-Associated Disease within a Veterans Administration Health Care System | Zendy

Lynne V. McFarland | Zendy; Jill E. Clarridge | Zendy; H. Beneda | Zendy; Gregory J. Raugi | Zendy

Open Access

Fluoroquinolone Use and Risk Factors for Clostridium difficile-Associated Disease within a Veterans Administration Health Care System

Author(s) -

Lynne V. McFarland,

Jill E. Clarridge,

H. Beneda,

Gregory J. Raugi

Publication year - 2007

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/522187

Subject(s) - medicine , clostridium difficile , diarrhea , odds ratio , incidence (geometry) , confidence interval , enterocolitis , retrospective cohort study , clindamycin , rate ratio , antibiotics , microbiology and biotechnology , physics , optics , biology

Prompted by the changing profile of Clostridium difficile infection and the impact of formulary policies in hospitals, we performed this study when an increase in the incidence of C. difficile-associated disease was noted at our health care center (Veterans Administration Puget Sound Health Care System, Seattle, Washington).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research